Fischer Laurent
SEC insider (Form 3/4/5 filer). CIK 0001379344. Director at Lycia Therapeutics, Inc. (LYCA) and 4 other issuers. 45 reported Form 4/5 transactions since Sep 2024; latest on Sep 11, 2026. Located in SOUTH SAN FRANCISCO, CA.
Companies Fischer Laurent has filed insider reports for
- Lycia Therapeutics, Inc. (LYCA): Director
- AtaiBeckley Inc. (ATAI): Director
- Mirum Pharmaceuticals, Inc. (MIRM): Director
- Adverum Biotechnologies, Inc. (ADVM): Director, Officer, CEO, PRESIDENT AND DIRECTOR
- ATAI Life Sciences N.V. (ATAI): Director
Fischer Laurent
CIK: 0001379344
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (45 total)
- Sep 11, 2026ATAI
AtaiBeckley Inc.
DispositionDirectStock Option
122K shares- - Sep 11, 2026ATAI
AtaiBeckley Inc.
DispositionDirectStock Option
103K shares- - Sep 11, 2026ATAI
AtaiBeckley Inc.
DispositionDirectStock Option
206K shares- - Jun 15, 2026MIRM
Mirum Pharmaceuticals, Inc.
AwardDirectDeferred Stock Units
2K shares- - Jun 15, 2026MIRM
Mirum Pharmaceuticals, Inc.
AwardDirectStock Option (right to buy)
3.8K shares- - Jun 4, 2026ATAI
AtaiBeckley Inc.
AwardDirectStock Option
122K shares- - May 29, 2026MIRM
Mirum Pharmaceuticals, Inc.
ExerciseDirect4K shares- - Dec 9, 2025ADVM
Adverum Biotechnologies, Inc.
ExerciseDirect150K shares at avg. $4.20$630K - Dec 9, 2025ADVM
Adverum Biotechnologies, Inc.
Tender OfferDirect25K shares- - Dec 9, 2025ADVM
Adverum Biotechnologies, Inc.
DispositionDirectStock Option (Right to Buy)
200K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 11, 2026 |  ATAI AtaiBeckley Inc. | Disposition Stock Option | 121,968 | - | - | Direct |
| Sep 11, 2026 | ATAI AtaiBeckley Inc. | Disposition Stock Option | 103,000 | - | - | Direct |
| Sep 11, 2026 | ATAI AtaiBeckley Inc. | Disposition Stock Option | 206,000 | - | - | Direct |
| Jun 15, 2026 |  MIRM Mirum Pharmaceuticals, Inc. | Award Deferred Stock Units | 1,980 | - | - | Direct |
| Jun 15, 2026 | MIRM Mirum Pharmaceuticals, Inc. | Award Stock Option (right to buy) | 3,772 | - | - | Direct |
| Jun 4, 2026 | ATAI AtaiBeckley Inc. | Award Stock Option | 121,968 | - | - | Direct |
| May 29, 2026 | MIRM Mirum Pharmaceuticals, Inc. | Exercise | 3,977 | - | $0 | Direct |
| Dec 9, 2025 |  ADVM Adverum Biotechnologies, Inc. | Exercise | 150,000 | $4.20 | $630,000 | Direct |
| Dec 9, 2025 | ADVM Adverum Biotechnologies, Inc. | Tender Offer | 25,000 | - | - | Direct |
| Dec 9, 2025 | ADVM Adverum Biotechnologies, Inc. | Disposition Stock Option (Right to Buy) | 200,000 | - | - | Direct |
1-10 of 45 transactions